ADMA Biologics Inc.

NASDAQ: ADMA · Real-Time Price · USD
16.95
-0.02 (-0.12%)
At close: Aug 15, 2025, 3:59 PM
17.00
0.29%
After-hours: Aug 15, 2025, 06:05 PM EDT

ADMA Biologics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
197.67M -28.24M -65.9M -71.65M
Depreciation & Amortization
8.04M 8.33M 7.11M 5.5M
Stock-Based Compensation
13.62M 6.19M 5.21M 3.49M
Other Working Capital
-2.78M 7.58M 6.4M 5.49M
Other Non-Cash Items
-78.92M 32.64M 12.35M 1.75M
Deferred Income Tax
n/a n/a n/a 220.76K
Change in Working Capital
-18.54M -10.12M -18.29M -51.68M
Operating Cash Flow
118.67M 8.8M -59.51M -112.37M
Capital Expenditures
-8.57M -4.98M -13.91M -13.51M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-349K -210K n/a n/a
Investing Cash Flow
-8.57M -4.98M -13.91M -13.51M
Debt Repayment
-60M -23.6M 51.71M -34K
Common Stock Repurchased
n/a -1.42M n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.7M -13.97M -7.51M -62K
Financial Cash Flow
-58.3M -38.99M 108.85M 121.05M
Net Cash Flow
51.8M -35.17M 35.43M -4.83M
Free Cash Flow
110.1M 3.82M -73.42M -125.88M